Business news

Electrotherapy Market Size Forecasted to Reach Valuation of USD 1.30 Billion in 2028

Electrotherapy Market Size

Research on the global electrotherapy market size shows the market is expected to reach USD 1.30 billion in 2028 and register a CAGR of 3.9% throughout the forecast period. Technological advancements in medical sector is predicted to boost revenue growth of the electrotherapy market.

Electrotherapy is a painless and non-invasive treatment that uses electric currents to stimulate muscles and nerves. These are battery-operated devices attached by wires and adhesive electrode pads that are placed on the skin surface and low-intensity currents are passed across affected area. Electrotherapy is used in various medical applications including, pain management, tissue repair, and cardiology. It is mainly used to restore a range of motions, improve blood circulation, sensation, and muscle strength. Electrotherapy is most commonly used by therapists and athletes for management of sports injuries. Increasing incidence of sports injuries and chronic pain is fueling demand for electrotherapy.

Rising awareness about adverse effects of painkillers is augmenting demand for electrotherapy among patients suffering from severe and chronic nerve pain. In addition, increasing geriatric population has led to a rise in incidence of chronic diseases globally and is expected to boost revenue growth of the global market for electrotherapy during the forecast period.

However, low awareness regarding utilization of electrotherapy techniques in developing economies along with availability of better alternatives to electrotherapy in some developed countries is expected to restrain market growth to some extent over the forecast period.

Grab Your Free Sample PDF Copy Now

Some key highlights in the report:

  • In 2020, Transcutaneous Electrical Nerve Stimulation (TENS) segment accounted for a high market revenue share in the global electrotherapy market and is projected to register a significantly high CAGR during the forecast period. These systems are used for treating chronic pain and nerve pain, and rising incidence is further expected to support deployment, and hence, market growth.
  • The acute & chronic edema segment accounted for highest revenue share contribution to the global market in 2020 owing to growing geriatric population and rising incidence of nerve and chronic pain.
  • North America accounted for largest revenue share in the global electrotherapy market and is likely to register a robust CAGR throughout the forecast period. United States and Canada are the highest revenue contributors in North America. This growth is attributed to major developments in healthcare infrastructure, rising implementation of electrotherapy for treating sports injuries, and presence of major electrotherapy manufacturing companies in countries in the region.
  • The market in Europe contributed second-largest market revenue share in 2020, which is projected to increase significantly between 2021 and 2028 due to advancements in technology and increasing need for pain management and treatment.
  • Key players operating in the market are Medtronic Plc., AliMed, Inc., St. Jude Medical Inc., Cogentix Medical, Inc., Zynex Medical, NeuroMetrix Inc., DJO Global Inc., Cyberonics Inc., Nevro Corp., and Boston Scientific Corp.
  • Omron Healthcare launched Avail, which is its first TENs unit, in January 2018, to manage chronic and acute pain syndrome. This device can be operated using Omron’s application on smartphones as well.

For the purpose of this report, Emergen Research has segmented the global electrotherapy market based on treatment type, application, end-use, and region:

Treatment Type Outlook (Revenue: USD Million; 2018–2028)

  • Transcutaneous Spinal Electro analgesia (TSE)
  • Interferential Current Therapy (IC)
  • Pulsed Short Wave Diathermy (PSWD)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Spinal Cord Stimulation (SCS)
  • Electro-Acupuncture (EA)
  • Percutaneous Electrical Nerve Stimulation (PENS)
  • Others

Application Outlook (Revenue: USD Million; 2018–2028)

  • Sports Injury
  • Neuromuscular Dysfunction
  • Tissue Repair
  • Urine and Fecal Incontinence
  • Iontophoresis
  • Pain Management
  • Acute and Chronic Edema

End-Use Outlook (Revenue: USD Million; 2018–2028)

  • Rehabilitation Centers
  • Long-term Care Centers
  • Clinics
  • Hospitals
  • Others

Regional Outlook (Revenue: USD Million; 2018–2028)

North America

  • U.S.
  • Canada


  • Germany
  • U.K.
  • France
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Rest of LATAM

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

To get leading market solutions, visit the link below:

To Top

Pin It on Pinterest

Share This